Importantly, whereas TLR9 was previously thought to be expressed only on immune cells, it has been shown that it also expressed on a number of different cancers (oral, prostate, breast, lung, Burkitt lymphoma), and signaling through TLR9 promotes proliferation and/or cell survival (37–44). This evidence concerns the gene TLR9 and Burkitt lymphoma.